292 related articles for article (PubMed ID: 16181340)
1. The lysosomal cysteine proteases in MHC class II antigen presentation.
Hsing LC; Rudensky AY
Immunol Rev; 2005 Oct; 207():229-41. PubMed ID: 16181340
[TBL] [Abstract][Full Text] [Related]
2. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal cysteine proteases and antigen presentation.
Rudensky A; Beers C
Ernst Schering Res Found Workshop; 2006; (56):81-95. PubMed ID: 16329647
[TBL] [Abstract][Full Text] [Related]
4. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
[TBL] [Abstract][Full Text] [Related]
5. Asparaginyl endopeptidase: case history of a class II MHC compartment protease.
Watts C; Matthews SP; Mazzeo D; Manoury B; Moss CX
Immunol Rev; 2005 Oct; 207():218-28. PubMed ID: 16181339
[TBL] [Abstract][Full Text] [Related]
6. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
[TBL] [Abstract][Full Text] [Related]
7. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
Manoury B; Gregory WF; Maizels RM; Watts C
Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal cysteine proteases regulate antigen presentation.
Honey K; Rudensky AY
Nat Rev Immunol; 2003 Jun; 3(6):472-82. PubMed ID: 12776207
[TBL] [Abstract][Full Text] [Related]
9. The labyrinth unfolds: architectural rearrangements of the endolysosomal system in antigen-presenting cells.
Perrin P; Jongsma ML; Neefjes J; Berlin I
Curr Opin Immunol; 2019 Jun; 58():1-8. PubMed ID: 30738283
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.
Li P; Gregg JL; Wang N; Zhou D; O'Donnell P; Blum JS; Crotzer VL
Immunol Rev; 2005 Oct; 207():206-17. PubMed ID: 16181338
[TBL] [Abstract][Full Text] [Related]
12. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.
Nakagawa TY; Rudensky AY
Immunol Rev; 1999 Dec; 172():121-9. PubMed ID: 10631942
[TBL] [Abstract][Full Text] [Related]
13. Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.
Villadangos JA; Driessen C; Shi GP; Chapman HA; Ploegh HL
EMBO J; 2000 Mar; 19(5):882-91. PubMed ID: 10698930
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation.
Costantino CM; Hang HC; Kent SC; Hafler DA; Ploegh HL
J Immunol; 2008 Mar; 180(5):2876-85. PubMed ID: 18292509
[TBL] [Abstract][Full Text] [Related]
15. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs.
Bania J; Gatti E; Lelouard H; David A; Cappello F; Weber E; Camosseto V; Pierre P
Proc Natl Acad Sci U S A; 2003 May; 100(11):6664-9. PubMed ID: 12748383
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
[TBL] [Abstract][Full Text] [Related]
17. Cysteine cathepsins in the immune response.
Zavasnik-Bergant T; Turk B
Tissue Antigens; 2006 May; 67(5):349-55. PubMed ID: 16671941
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.
Lich JD; Elliott JF; Blum JS
J Exp Med; 2000 May; 191(9):1513-24. PubMed ID: 10790426
[TBL] [Abstract][Full Text] [Related]
19. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
Hsieh CS; deRoos P; Honey K; Beers C; Rudensky AY
J Immunol; 2002 Mar; 168(6):2618-25. PubMed ID: 11884425
[TBL] [Abstract][Full Text] [Related]
20. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
